The Value of 68Ga-FAPI PET/CT in Preoperative Evaluation of Thyroid Cancer with Lymph Node Metastases

Sponsor
Ruijin Hospital
Study ID
NCT06730529
Status
Recruiting
Apply to this trial

Conditions

  • Thyroid Cancer

Eligibility Criteria

Sex
ALL
Age
16 Years - 80 Years
Healthy Volunteers
Not accepted

Study Details

This study aims to investigate the value of 68Ga-FAPI in the preoperative evaluation of thyroid cancer of different pathologic types.

Key Dates

First listed
Dec 12, 2024
Start date
Nov 29, 2024
Status verified
Dec 2024
Primary completion
Dec 31, 2029
Completion
Dec 31, 2029

Study Design

Enrollment
40 participants (estimated)

Arms

  • Arm: Patients diagnosis of thyroid cancer with lymph node metastases

Primary Outcome Measure

Clinical staging of thyroid cancer with lymph node metastasis [ Time Frame: Within 1 week after enrollment ]

Central Contacts

Related Studies